Neural Therapeutics Inc. (CSE:NURL)

Neural Therapeutics Cash Flow Statement

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jan 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Net Income	-0.55	-0.67	-1.08	-1.82
Other Operating Activities	0.02	0.05	-0.01	1.08
Change in Accounts Payable	-0.09	0.02	0.42	0.22
Change in Other Net Operating Assets	0.55	0.28	0.14	-0.08
Operating Cash Flow	-0.08	-0.32	-0.53	-0.6
Short-Term Debt Issued	-	0.01	-	0.23
Total Debt Issued	0.01	0.01	-	0.23
Net Debt Issued (Repaid)	0.01	0.01	-	0.23
Issuance of Common Stock	0.52	0.11	0.43	0.79
Other Financing Activities	-	-0.01	-	-0.04
Financing Cash Flow	0.53	0.11	0.43	0.97
Net Cash Flow	0.45	-0.21	-0.1	0.37
Levered Free Cash Flow	-0.42	-0.54	-0.74	-
Unlevered Free Cash Flow	-0.42	-0.54	-0.74	-
Change in Net Working Capital	0.09	0.13	-0.01	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.